title: [123I-Metaiodobenzylguanidine- (MIBG-) scintigraphy: paradoxical positivity in an oncocytic adrenocortical carcinoma].
abstract: (123)I-metaiodobenzylguanidine (MIBG), a radio-labeled catecholamine analogue, is used for the imaging of pheochromocytoma based on the selective uptake of MIBG by chromaffin tissues. MIBG scintigraphy displays high sensitivity (90%) and specificity (close to 100%). In contrast, the false-positive uptake of MIBG by adrenal cortical carcinoma is rare. Here, we report a metastatic oncocytic adrenal cortical carcinoma with MIBG uptake used for therapeutic purposes.
authors: Institut für Klinische Pathologie, Universitätsspital, Schmelzbergstrasse 12, 8091, Zürich, Schweiz. barbara.padberg@usz.ch
authors: B-C
authors: BC
authors: Padberg
authors: T
authors: T
authors: Rordorf
authors: S L
authors: SL
authors: Suter
authors: D
authors: D
authors: Pfeiffer
authors: D
authors: D
authors: Wild
authors: S
authors: S
authors: Schröder